Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

SynAct Pharma announces attendance and presentation at upcoming investor conferences

SynAct Pharma AB (publ) (“SynAct”) (Nasdaq Stockholm: SYNACT), a clinical-stage biotechnology company focused on treating inflammation through a novel therapeutic approach known as “pro-resolution”, today announces its attendance at upcoming investor conferences through the fourth quarter of 2026.

BIO-Europe, November 9-11, Cologne, Germany

Chief Business Officer Mads Bjerregaard attending.

BIO-Europe brings together thousands of leading representatives of the biotech and pharmaceutical industry as well as investors from over 60 countries. The aim is to make connections and accelerate the path from innovation to impact.

Pharma Outsourcing, December 2, Stockholm, Sweden

Presentation: Beyond Licensing – Building Partnerships Across Indications That Shares Risk and Creates Value
Presenting: Mads Bjerregaard
Time: 11:55am CET

Interested parties are invited to contact SynAct Pharma via the respective conference partnering systems to arrange a one-on-one meeting during the events.